Information For Authors
The abstract should be uploaded in the form of a Microsoft Word file.
The abstract must contain 5 parts written in the following order: Background, Aim, Methods, Results and Conclusion. The case report must contain 4 parts written in the following order: Introduction, Case description, Discussion and Conclusion. Templates are available at our official web site.
The abstract should not exceed 300 words. Keywords, title and titles of abstract parts (e.g. Background, Aim, Methods, Results and Conclusion) are not included into the word count.
The abstract should be written in Arial font and prepared as indicated in the template offered at the official web site.
The title must be short, clearly indicating the objective of the research. Only first letter of each word in the title should be capitalized. Do not include any abbreviations or commercial names of the drugs.
Full name of the first author should be written in CAPITAL LETTERS and the name of co-author(s) in lower-case letters.
It is not permitted to include tables, charts or pictures in your abstract.
Please write 3 to 5 keywords that best describe your research at the end of the abstract.
Correspondence details
The author submitting an abstract to the OJS platform will be considered as a corresponding author. The email address used for registration will be considered as the email address for correspondence.
Review process
Every abstract will be reviewed at least two times.
During the first review, abstracts will be checked for number of words and plagiarism.
The second review will be conducted by the specialist of the medical area that the abstract was assigned to.
The review process is a straightforward procedure and will be conducted through the OJS platform.
For any questions regarding platform usage, author can contact technical support via the following email: hamza.izeta1@gmail.com
Authors will get an email notification after they submit their abstracts, as well as for each step taken by the editors. Therefore, we kindly ask you to check your email (including your spam folder).
The abstract must contain 5 parts written in the following order: Background, Aim, Methods, Results and Conclusion. The case report must contain 4 parts written in the following order: Introduction, Case description, Discussion and Conclusion. Templates are available at our official web site.
The abstract should not exceed 300 words. Keywords, title and titles of abstract parts (e.g. Background, Aim, Methods, Results and Conclusion) are not included into the word count.
The abstract should be written in Arial font and prepared as indicated in the template offered at the official web site.
The title must be short, clearly indicating the objective of the research. Only first letter of each word in the title should be capitalized. Do not include any abbreviations or commercial names of the drugs.
Full name of the first author should be written in CAPITAL LETTERS and the name of co-author(s) in lower-case letters.
It is not permitted to include tables, charts or pictures in your abstract.
Please write 3 to 5 keywords that best describe your research at the end of the abstract.
Correspondence details
The author submitting an abstract to the OJS platform will be considered as a corresponding author. The email address used for registration will be considered as the email address for correspondence.
Review process
Every abstract will be reviewed at least two times.
During the first review, abstracts will be checked for number of words and plagiarism.
The second review will be conducted by the specialist of the medical area that the abstract was assigned to.
The review process is a straightforward procedure and will be conducted through the OJS platform.
For any questions regarding platform usage, author can contact technical support via the following email: hamza.izeta1@gmail.com
Authors will get an email notification after they submit their abstracts, as well as for each step taken by the editors. Therefore, we kindly ask you to check your email (including your spam folder).
